Discover 722 paid clinical trials in Overland Park, Kansas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 722
A Study of Buntanetap in Participants With PD
for
Parkinson's Disease (PD), Deep Brain Stimulation
Location: Kansas City KS, Tulsa OK, Memphis TN, Cordova TN,
Sponsor: Annovis Bio Inc.
Sex: All
Age: 40 - 70+
Code: NCT07284784
Phase2, Phase3, Recruiting
Dry Needling in Multiple Sclerosis
for
Multiple Sclerosis, Spasticity
Location: Kansas City KS
Sponsor: University of Kansas Medical Center
Sex: All
Age: 18 - 64
Code: NCT06394310
Recruiting
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
for
Prostate Cancer
Location: Merriam KS, St Louis MO, Sioux Falls SD, Irving TX,
Sponsor: Amgen
Sex: Male
Age: 18+
Code: NCT04221542
Phase1, Recruiting
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
for
Obesity or Overweight, Diabetes Mellitus, Type 2
Location: Lenexa KS, Franklin TN, Fairhope AL, North York,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07784270
Phase3, Recruiting
A Clinical Study to Investigate the Safety and Immunogenicity of rVSV∆G-SUDV-GP, a Sudan Virus (SUDV) Vaccine for the Prevention of SUDV Disease in Adults in Good General Health
for
Sudan Virus Disease
Location: Lenexa KS, Washington D.C. DC, Boston MA
Sponsor: International AIDS Vaccine Initiative
Sex: All
Age: 18 - 50
Code: NCT07565090
Phase1, Recruiting
Safety, Tolerability and Pharmacokinetics of AZD1613 in Adults With Autosomal Dominant Polycystic Kidney Disease
Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
for
B-cell Acute Lymphoblastic Leukemia, Obesity
Location: Kansas City KS, Minneapolis MN, Chicago IL, Dallas TX,
Sponsor: Etan Orgel
Sex: All
Age: 7 - 25
Code: NCT05082519
Phase2, Recruiting
Continuous Monitoring and Control of Hypoglycemia
for
Diabetes
Location: Kansas City MO, Topeka KS, Oklahoma City OK,
Sponsor: DexCom, Inc.
Sex: All
Age: 2+
Code: NCT03340831
Recruiting
Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
for
Atypical Teratoid/Rhabdoid Tumor,
Location: Kansas City KS, St Louis MO, Little Rock AR, Dallas TX,
Sponsor: Milton S. Hershey Medical Center
Sex: All
Age: 0 - 26
Code: NCT06465199
Phase1, Phase2, Recruiting
A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)
for
Rhabdomyosarcoma
Location: Kansas City MO, Wichita KS, Omaha NE, Des Moines IA,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 50
Code: NCT07466316
Phase3, Recruiting
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
for
B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma,
Location: Kansas City MO, Columbia MO, Wichita KS, Omaha NE,
Sponsor: Children's Oncology Group
Sex: All
Age: 1 - 25
Code: NCT03959085
Phase3, Recruiting
Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma
for
Embryonal Rhabdomyosarcoma,
Location: Kansas City MO, Wichita KS, Omaha NE, Des Moines IA,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 21
Code: NCT05304585
Phase3, Recruiting
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
for
Childhood Extracranial Germ Cell Tumor,
Location: Kansas City MO, Osage Beach MO, Columbia MO, Creston IA,
Sponsor: Children's Oncology Group
Sex: All
Age: 0+
Code: NCT03067181
Phase3, Recruiting
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab